Additionally, recent works have highlighted NPTX2 as a key component of TDP‐43 pathology,59 and showed that its serum levels correlate with the survival rate of an heterogenous cohort of ALS patients.60 This evidence concerns the gene NPTX2 and amyotrophic lateral sclerosis.